Company / Revenue
GeneDx Holdings Corp. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$427.5M
FY2025
5-year range
$179.3M / $427.5M
FY2021-FY2025
Trend
+40.0%
vs FY2024
Sector context
#125 of 156
Health Care
What the data says
GeneDx Holdings Corp.'s revenue of $428M is lower than 80% of companies in the Health Care sector (FY2025). Revenue has increased for 3 consecutive years, from $179M in FY2022 to $428M in FY2025.
Based on SEC 10-K filings.
$428M in FY2025 with a 5-year CAGR of +19.0%.
Improved from $203M to $428M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +33.6%
- 5-Year CAGR
- +19.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 156This company $427.5M Sector average $19.0B
▼
-97.8% below sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s revenue has grown for 3 consecutive years.
- 5-year CAGR of +19.0%, indicating consistent growth.
- In FY2025, revenue increased 40.0% year-over-year.
- Ranks #125 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $427.5M | +40.0% |
| FY2024 | $305.4M | +50.8% |
| FY2023 | $202.6M | +13.0% |
| FY2022 | $179.3M | -15.5% |
| FY2021 | $212.2M | +18.3% |
| FY2020 | $179.3M | -8.6% |
| FY2019 | $196.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026